Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2014
09/25/2014WO2014149529A1 Coated phenylephrine particles and use thereof in pharmaceutical formulations
09/25/2014WO2014149526A1 Phenylephrine resinate particles
09/25/2014WO2014149525A1 Phenylephrine resinate particles and use thereof in pharmaceutical formulations
09/25/2014WO2014149397A1 Compositions comprising an opioid and an additional active pharmaceutical ingredient for rapid onset and extended duration of analgesia that may be administered without regard to food
09/25/2014WO2014149390A1 Uv-absorbing polymers and formulations thereof
09/25/2014WO2014149160A1 Polyalkoxylated alcohols as excipients for pharmaceutical compositions
09/25/2014WO2014148997A1 Hollow calcium phosphate particles
09/25/2014WO2014148951A1 Novel therapeutic mirtazapine combinations for use in pain disorders
09/25/2014WO2014148883A1 Herbaceutical formulations
09/25/2014WO2014148881A1 Gelatinous mixture of probiotics and prebiotics with synergic symbiotic action for treating chronic renal disease
09/25/2014WO2014148765A1 Dental nanofiber chip equipped with medication and method for manufacturing same
09/25/2014WO2014148582A1 Solventless polyurethane-based adhesive
09/25/2014WO2014148520A1 Solid preparation
09/25/2014WO2014148450A1 Two-layer separation-type eye drop containing squalane
09/25/2014WO2014148244A1 Oral composition
09/25/2014WO2014147608A1 Magnetic inorganic iron-based nanoparticles
09/25/2014WO2014147568A1 Sterile s-adenosyl methionine with a high content of active isomer for injectable solutions, and procedure for obtaining it
09/25/2014WO2014147567A1 Pharmaceutical compositions comprising everolimus
09/25/2014WO2014147526A1 Tofacitinib oral sustained release dosage forms
09/25/2014WO2014147377A1 An oral dosage form having an outer surface comprising a medicated print
09/25/2014WO2014147242A1 Piperaquine microcapsules and compositions containing them
09/25/2014WO2014147131A1 Allergen preparation
09/25/2014WO2014147096A1 Pharmaceutical compositions comprising an active agent
09/25/2014WO2014146975A1 FORMULATION OF AMORPHOUS CALCIUM L-5-METHYLTETRAHYDROFOLATE (L-5-MTHF-Ca)
09/25/2014WO2014146775A1 Pharmaceutical composition comprising a fluoroquinolone antibacterial agent and method for the preparation thereof
09/25/2014WO2014146677A1 Peg hydrogels functionalized with glucagon and rgds-tetrapeptide and containing stem cells for islet coating
09/25/2014WO2014146345A1 Tonic wine for dispelling rheumatism
09/25/2014WO2014146202A1 Bacteria for the prevention, treatment and diagnosis of breast cancer
09/25/2014US20140288623 Apparatus for treating cerebral neurovascular disorders including headaches by neural stimulation
09/25/2014US20140288495 Timed release capsule and device for use with beverages
09/25/2014US20140288491 Composition for the Treatment of Fistula
09/25/2014US20140288481 Transdermal patch with non-water soluble adhesive and anesthetic
09/25/2014US20140288266 Synthesis of Cyclosporin Analogs
09/25/2014US20140288189 Water-Stable Hydrogel and Method Using Same
09/25/2014US20140288160 Cleavable lipids
09/25/2014US20140288137 Compositions and methods of treatment of inflammatory skin conditions using allantoin
09/25/2014US20140288122 Method for inhibiting platelet aggregation
09/25/2014US20140288114 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
09/25/2014US20140288102 Prevention of recurrences of urethral strictures following conventional therapy
09/25/2014US20140288038 Device for transdermal administration of drugs including acrylic polymers
09/25/2014US20140287998 Glucagon formulations
09/25/2014US20140287053 Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
09/25/2014US20140287052 Treatment of adrenal insufficiency
09/25/2014US20140287051 Orally administered corticosteroid compositions
09/25/2014US20140287048 Paste comprising non-steroidal anti-inflammatory drug
09/25/2014US20140287045 Method of preparing microspheres by using polymer having sol-gel transition property and microspheres prepared thereby
09/25/2014US20140287043 Compositions and methods for stabilization of active agents
09/25/2014US20140287042 Oral Tablet Formulation Consisting Of Fixed Combination Of Rosuvastatin And Ezetimibe For Treatment Of Hyperlipidemia And Cardiovascular Diseases
09/25/2014US20140287041 Methylphenidate Extended Release Chewable Tablet
09/25/2014US20140287040 Formulation
09/25/2014US20140287039 Abiraterone Acetate Formulation
09/25/2014US20140287038 Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product
09/25/2014US20140287037 Extended-release topiramate capsules
09/25/2014US20140287036 Soft-gelatin capsule formulation
09/25/2014US20140287035 Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency
09/25/2014US20140287034 Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration
09/25/2014US20140287032 Treatment Method and Product for Uterine Fibroids using Purified Collagenase
09/25/2014US20140287028 Use of Chemotherapeutic Agents
09/25/2014US20140287027 Vesicle-encapsulated corticosteroids for the treatment of cancer
09/25/2014US20140287025 Sustained Release Composition For Local Injection to Treat Eye Diseases
09/25/2014US20140287024 Nanoparticle-based delivery system with oxidized phospholipids as targeting ligands for the prevention, diagnosis and treatment of atherosclerosis
09/25/2014US20140287022 Liposomal formulations
09/25/2014US20140287019 Implantable Devices for Delivery of Bioactive Agents
09/25/2014US20140287006 Degradation-Stabilised, Biocompatible Collagen Matrices
09/25/2014US20140287004 Use of an Omega-3 Lipid-Based Emulsion Following Ischemic Injury to Provide Protection and Recovery in Human Organs
09/25/2014US20140286891 Ion binding polymers and uses thereof
09/25/2014US20140286888 Self-assembling peptide and peptide gel with high strength
09/25/2014US20140286878 Composition for inhalation
09/25/2014US20140286877 Compositions comprising salbutamol sulphate
09/25/2014US20140286876 Veterinary active agent application
09/25/2014US20140286873 Polymer-agent conjugates, particles, compositions, and related methods of use
09/25/2014US20140286872 Nanoparticle for targeting brain tumors and delivery of o6-benzylguanine
09/25/2014DE102013204817A1 Verfahren zur Herstellung von sulfatierten Celluloseestern sowie hieraus hergestellte Mikrokapseln und deren Verwendung Process for the preparation of sulfated cellulose esters, and microcapsules produced therefrom and their use
09/24/2014EP2781225A1 Intestinal fibrosis treatment agent
09/24/2014EP2781215A1 Topical patch preparation for treatment of toxicity of mosquitoes
09/24/2014EP2781214A1 Formulation of amorphous calcium L-5-methyltetrahydrofolate (L-5-MTHF-Ca)
09/24/2014EP2781213A1 Method of preparing microspheres by using polymer having sol-gel transition property and microspheres prepared thereby
09/24/2014EP2781212A1 Long-acting formulations of insulins
09/24/2014EP2780036A1 Nanoparticle compositions for generation of regulatory t cells and treatment of autoimmune diseases and other chronic inflammatory conditions
09/24/2014EP2780006A1 Composition for transdermal administration of rivastigmine
09/24/2014EP2780005A1 Controlled release of active using ph
09/24/2014EP2780004A1 Film-forming formulation
09/24/2014EP2780003A1 Treatment of adrenal insufficiency
09/24/2014EP2780002A1 Oral complex formulation comprising omega-3 fatty acid and hmg-coa reductase inhibitor with improved stability
09/24/2014EP2780001A2 Fast release solid oral compositions of entecavir
09/24/2014EP2780000A1 Tamper-resistant oral pharmaceutical dosage form comprising a pharmacologically active ingredient, an opioid antagonist and/or aversive agent, polyalkylene oxide and anionic polymer
09/24/2014EP2779999A2 Pharmaceutical formulations comprising atorvastatin and glimepiride
09/24/2014EP2779998A1 Polymeric colorant compositions and methods of use
09/24/2014EP2779997A1 Liquid-filled hard gel capsule pharmaceutical formulations
09/24/2014EP2779996A1 Drug delivery system for sustained delivery of bioactive agents
09/24/2014EP2779995A1 Immediate release 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-[5-(4-methyl- 1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl]benzamide formulation
09/24/2014EP2779994A1 Suspensions of cyclosporin a form 2
09/24/2014EP2779993A1 Autoclavable suspensions of cyclosporin a form 2
09/24/2014EP2779992A1 Sustained action formulation of cyclosporin form 2
09/23/2014US8841446 Medicaments containing vardenafil hydrochloride trihydrate
09/23/2014US8841351 Polymeric topical compositions
09/23/2014US8841345 Compositions and methods for treatment of premature ejaculation
09/23/2014US8841342 Carrier
09/23/2014US8841303 Melt-processed imatinib dosage form
09/23/2014US8841286 Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 2991